Added Clinically reviewed
CASCADE: mechanisms, evidence & therapeutic decisions
CASCADE · Professional learning · English
See how a therapy works. Examine what the evidence supports. Bring both into a thoughtful clinical decision.
Choose your starting point
Take the complete learning sequence or open the activity that fits your question. Each module retains its own visual language and interactive tools.
Interactive mechanism
Explore the mechanism
Follow extracellular IL-23 receptor blockade through an animated, seven-step molecular walkthrough.
Open activityGuided learning + quiz
Study the evidence
Connect the mechanism with real psoriasis evidence, safety interpretation and the limits of a treatment indication.
Open activityThree-stage clinical case
Apply clinical reasoning: George
Balance patient priorities, diagnostic uncertainty and conditional treatment plans in psoriasis and suspected PsA.
Open activityReviewed
One pathway. Different clinical questions.
These activities distinguish molecular mechanism, plaque-psoriasis evidence and the assessment of suspected or established psoriatic arthritis. A shared signaling pathway does not establish a treatment indication.
Professional access
Sign in with your registered RheumaView account to open these clinical learning modules and keep your progress.
Sign in to continueRead alongside the modules
Keep receptor-level mechanisms in context with intracellular signaling and disease-specific assessment.
JAK & TYK2 signaling →Spondyloarthritis collection →Know what your result means
Knowledge results and engagement points serve different purposes. Learning milestones are personal records; these activities do not award CME credit.
Evidence, disclosures & review →Daniela’s SLE journey: mechanism, decisions and follow-up
Explore three interactive modules on systemic lupus erythematosus (SLE), from treatment mechanisms to clinical reasoning and a year of follow-up.
Open access — no registration required. These three modules are temporarily available to everyone.
Break the Loop: Type I Interferon Receptor Blockade in SLE
Explore type I interferon signaling, Saphnelo (anifrolumab), clinical evidence and patient selection through Daniela’s SLE case, a narrated mechanism film and interactive checks.
Open module 1: Break the Loop: Type I Interferon Receptor Blockade in SLE
Daniela: What Comes Next?
Work through a three-stage SLE clinical reasoning case: identify Daniela’s priorities, weigh the medical facts, and rank treatment options for lupus that remains active on standard therapy.
Open module 2: Daniela: What Comes Next?
Daniela: The First 52 Weeks
Guide Daniela through a year of Saphnelo (anifrolumab) treatment in this SLE simulation. Make decisions about vaccination, infusion reactions, prednisone tapering, infections, home injections and follow-up, then review the illustrated course.